• Having departed from his previous position as AstraZeneca's (London, UK) regional medical director–Asia Pacific, Dr. Ross Horsburgh will now oversee Kendle's (Cincinnati, OH) Asia/Pacific operations as the company's new vice president of global clinical development–Asia/Pacific. Additionally, Kendle recently welcomed Philip Davies—former director of global exploratory and program phase medical operations for Eli Lilly (Indianapolis, IN)—as vice president–Phase I.
Dr. Ross Horsburgh
• Inclinix (Wilmington, NC) made some changes to its executive management team. Steven Agnoff began working as vice president of marketing and product management; Daniel Marks joined the company as vice president of corporate development; Jeffrey Bagshaw has taken on the role of senior vice president of sales; and Susan Jalbert comes to Inclinix as director of North American sales.
• Due to increased business at Criterium's (Saratoga Springs, NY) India office, the company hired a few new staff members, including Dr. Vikrant Korde, a clinical research associate; Swapnil Shewale, a project assistant; and Nikhil Kajale, a clinical research associate. Furthermore, Garima Singh, formerly a project trainee for Criterium India, was promoted to clinical research associate, and Susan Blackburn has joined the NY headquarters as clinical data liaison.
• Dr. Barry Anderson brings his 20 years of experience in cancer research and treatment to Theradex (Princeton, NJ) as the company's vice president of clinical research affairs.
• Parexel's (Boston, MA) medical communications services business found a new vice president and general manager in Jacque Fisher, who will be responsible for leading a team in translating scientific information into integrated communications, as well as fulfilling client management and advisory roles.
• CardioVascular BioTherapeutics (Las Vegas, NV) hired Dr. Nabil Dib—director of cardiovascular research at AZ-based Catholic Healthcare West's Chandler Regional Medical Center and Mercy Gilbert Medical Center, and assistant professor of medicine and director of clinical cardiovascular cell therapy at the University of California, San Diego—as the principal investigator in a Phase II coronary heart disease study.
• With more than 12 years of medical photographic experience, Holly Smith will now serve as director of Profect Medical Technologies' (Brewster, NY) new clinical imaging services division.
• Robert Gundel, who most recently worked as chief scientific officer for Arius Research (Toronto, Canada), is Elusys Therapeutics' (Pine Brook, NJ) new vice president of research.
• ACM-Pivotal increased staff at its UK and U.S. sites, located in York, UK, and Rochester, NY. In the UK, Helen Jenkinson is senior clinical laboratory scientist, Laura Williams is senior project manager, Dean Thompson is logistics manager, and Andrew Botham is a senior scientist, while Chris Ellis and Shirley Macnamara received promotions to head of operations and head of business development, respectively. In the United States, Greg Grinstead is lead toxicologist, Tracy Hendershott is manager of global expansion, and Paul Herasimchuk is head of the data management team.
• Premier Research Group (Philadelphia, PA) recently welcomed Sebastien Duval—who previously had a senior business development role with CIT (Evreux, France)—as a business development director based in France.
• Carl Peck, founding director of the Center for Drug Development Science at the University of California, San Francisco, will now have a place on the Simcyp (Sheffield, UK) Scientific Advisory Board.
- LabConnect (Seattle, WA) signed Bostwick Scientific (Glen Allen, VA) as its exclusive provider of anatomic pathology testing services.
- Daiichi Sankyo (Tokyo, Japan) elected to renew its agreement with MorphoSys (Munich, Germany) to access HuCAL GOLD, the company's proprietary antibody library. The new collaboration will expire in March 2011.
- Image Solutions (ISI; Whippany, NJ) provided Boehringer Ingelheim (Ingelheim, Germany) with eCTDXPress, ISI's eCTD submissions software.
- AstraZeneca's (London, UK) global clinical development programs will use Cognizant's (Teaneck, NJ) centralized data management services under a five-year agreement projected to be worth $95 million.
- Laureate Pharma (Princeton, NJ) will manufacture Cytheris' (Paris, France) Interleukin-7, used to treat cancer, HIV, and HCV.
- Microsoft (Redmond, WA) will announce the winners of the 2008 Pharmaceutical and Life Sciences Innovation Awards in June at the annual DIA meeting in Boston, MA.
- Dr. Rabinder Buttar, president and chief executive officer of ClinTec (Glasgow, UK), was nominated for a Lloyds TSB (London, UK) Business & Commerce Excellence Jewel Award.
- Women in Bio (Bethesda, MD) honored 83 women entrepreneurs and founders of life sciences or biotech companies at its 6th annual meeting in Washington, DC, in March. Among the honorees: Laura Douglass, president and chief executive officer of Next Generation Clinical Research (Oregon, WI).
- Business Leader magazine and Wake Technical Community College (Raleigh, NC) recognized Metrics (Greenville, NC) as a "Business Champion" for its workplace education and developmental efforts for its employees.
- The Institute of Clinical Research's (Buckinghamshire, UK) Study Site Coordinators special interest group (SIG) has redirected its focus to the research nurse, and thus changed its name to the Research Nurses SIG.
- Over the course of the past year, the Alliance for Multispecialty Research (Nashville, TN) enrolled more than 18,000 subjects nationwide.
- Global Research Services (Rockville, MD) now offers a new service platform, called Private Label Reserve, for Phase I data management. The company also announced the expansion of its subsidiary, Shanghai, China-based Global Medical Consulting Services, which now provides full-service clinical trial management.
- In response to the growing acceptance and implementation of IVR solutions, IVR Clinical Concepts (Boca Raton, FL) introduced its International Advisory Council, which will aim to further the development and usage of Interactive Voice Technology.
- Biochrom (Cambridge, UK) is reportedly prepared to help health care providers screen patients for the genetic disorder Phenylketonuria. Because of the introduction of the first FDA-approved treatment for the condition, Biochrom anticipates a greater demand for screening and can provide the appropriate equipment and diagnostic reagents to test for the disorder.
- PharmaNet Development Group (Princeton, NJ) announced GAAP net earnings of $3.8 million for the fourth quarter 2007, up from $3.5 million in 2006.
- SapioSystems (Copenhagen, Denmark) released the latest version of its ScioSphere power workbench for patent and research analysis.
- Georgia Institute of Technology's (Atlanta, GA) Maysam Ghovanloo and Xueliang Huo designed a sensor necklace that identifies that date and time pills are swallowed—and alerts the user about missed doses—in the hopes of increasing drug compliance.
- Bio-Images Research (Glasgow, UK) piloted the imaGIT capsule, an ingestible, radio-controlled device for studying drug absorption.
- Bio-Imaging Technologies (Newtown, PA) increases its EDC capabilities with the $24 million acquisition of Phoenix Data Systems (King of Prussia, PA).
- Medidata Solutions (New York, NY) enhanced the company's clinical trial technology offerings through the purchase of Fast Track Systems (Conshohocken, PA).
- Aida Pharmaceuticals' (Santa Monica, CA) acquired Jiangsu Institute of Microbiology (Wuxi City, China), one of China's most prominent microbiology research institutes.
- Denver, CO-based Global Med Technologies entered into an agreement to buy Inlog (Lyon, France), a provider of medical software systems.
- Biodefense company PharmAthene (Annapolis, MD) acquired Avecia's (Manchester, UK) biodefense vaccines business, which boasts an anthrax vaccine and a plague vaccine, among others.
- MESM (Lancashire, UK), a new medical equipment supply firm, now offers "cradle to grave" service for the procurement, supply, and maintenance of medical equipment.
- Azopharma Product Development Group (Hollywood, FL) continues to grow, with plans to add 17 manufacturing suites to its Hollywood and Miramar, FL, facilities.
- PharmaZell (Raubling, Germany), a pharmaceuticals manufacturer, opened its second India-based development center in Vizag, having previously established one in Chennai.
- Tsukuba, Japan, is the new home of Biomedical Systems' (St. Louis, MO) Asian headquarters, which will be managed by Marcio Shiratusuchi.
- As part of an $18 million expansion aimed at doubling the size of its facility, Metrics (Greenville, NC) is currently increasing its stability storage.
- Franek Technologies (Tustin, CA) recently added distributors in the Caribbean, Central America, and Venezuela.
- Parexel (Boston, MA) expanded three of its clinical pharmacology research facilities in Baltimore, MD; Berlin, Germany; and London, UK.
- Cortegra has reportedly begun transferring its Fairfield, NJ-based corporate operations to the company's new headquarters in Parsippany, NJ.